Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer

29 May 2018

Abstract excerpt

We have previously shown that aberrant promoter methylation of ZNF331 is a potential biomarker for colorectal cancer detection with high sensitivity (71%) and specificity (98%). This finding was recently confirmed by others, and it was additionally suggested that promoter methylation of ZNF331 was an independent prognostic biomarker for colorectal cancer ( n = 146). In the current study, our initial colorectal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Epigenetics and DNA Methylation
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29854011
DOI: 10.1186/s13148-018-0503-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancerPMID 29854011Read ↗

Diagnostic Potential of Zinc Finger Protein-Specific Autoantibodies and Associated Linear B-Cell Epitopes in Colorectal CancerSemantic proximity Read ↗

Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressorSemantic proximity Read ↗

Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assaySemantic proximity Read ↗

Combining the DNA methylation markers of circulating tumor cells with immune infiltrating cells to assess recurrence and prognosis and to suggest a therapeutic strategy in stage III-IV colorectal cancerSemantic proximity Read ↗

Discovery and validation of tissue-specific DNA methylation as noninvasive diagnostic markers for colorectal cancerSemantic proximity Read ↗

Pan-Cancer Analysis of Tumor Suppressor ZNF132 Reveals Its Diagnostic and Prognostic Significance with Immunomodulatory Implications in Colorectal CancerSemantic proximity Read ↗

DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicineSemantic proximity Read ↗

Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.